Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : PTE save search
PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-16 (Crawled : 12:00) - prnewswire.com
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 1599.62%
H: 4.16%
C: -5.48%
results
PolarityTE Announces FDA Regenerative Medicine Advanced Therapy Designation Granted to SkinTE®
Published: 2022-05-13 (Crawled : 12:20) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 92.39%
H: 0.0%
C: 0.0%
skinte fda designation granted therapy grant
PolarityTE Announces Diabetic Foot Ulcer Trial Met Primary and Secondary Endpoint
Published: 2021-05-10 (Crawled : 16:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 29.34%
H: 9.52%
C: -4.76%
trial diabetic diabetes
PolarityTE Announces Formation of Strategic Review Committee
Published: 2021-01-11 (Crawled : 19:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 18.18%
H: 10.9%
C: -19.87%
ev
PolarityTE Announces Closing of $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Published: 2021-01-14 (Crawled : 22:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 14.78%
H: 0.76%
C: -8.33%
offering nasdaq
PolarityTE to Report Q1 2021 Financial Results on May 16, 2022
Published: 2022-05-06 (Crawled : 12:20) - prnewswire.com
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 3.96%
H: 0.53%
C: -7.94%
report results
PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE® to Support Chronic Cutaneous Ulcer Indication
Published: 2022-01-18 (Crawled : 15:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 3.81%
H: 11.07%
C: -3.92%
skinte fda fda approval skin approval phase 3
PolarityTE Submits Investigational New Drug Application for SkinTE® in Chronic Cutaneous Ulcers
Published: 2021-07-26 (Crawled : 13:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 3.21%
H: 0.62%
C: -2.53%
new drug drug skin application
Gatemore Capital Management LLP - Letter to the Board of Directors of PolarityTE, Inc.
Published: 2020-12-28 (Crawled : 14:07) - prnewswire.com
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 2.86%
H: 1.39%
C: -8.33%
PolarityTE Provides Corporate Update
Published: 2021-02-10 (Crawled : 15:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 2.6%
H: 4.43%
C: 3.8%
PolarityTE Announces Submission of Complete Response to FDA's Clinical Hold Correspondence for SkinTE® Investigational New Drug Application
Published: 2021-12-20 (Crawled : 14:30) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 2.56%
H: 8.75%
C: 8.7%
skinte clinical hold new drug fda application drug skin pons submission response
Stella Diagnostics Announces Leadership Changes: Dr. Joe Abdo Assumes a New Role as Chief Scientific Officer, and Director David Seaburg is Appointed Chief Executive Officer
Published: 2022-04-22 (Crawled : 14:20) - biospace.com/
SLDX | $0.0633 416.75% 230
|
Information
|
| O: 34.82%
H: 2.1%
C: 2.1%
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 2.19%
H: 7.95%
C: -1.1%
diagnostics diagnostic
PolarityTE to Report First Quarter Financial Results on May 13, 2021
Published: 2021-05-03 (Crawled : 13:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 1.96%
H: 0.0%
C: -1.92%
financial results results
PolarityTE Provides Update on Investigational New Drug Application
Published: 2021-10-07 (Crawled : 13:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 1.76%
H: 5.58%
C: -0.27%
new drug drug application
PTE Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies PolarityTE, Inc. Shareholders of Class Action and Encourages Investors to Contact the Firm
Published: 2021-09-30 (Crawled : 14:00) - prnewswire.com
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 1.19%
H: 0.37%
C: -0.09%
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against PolarityTE, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Published: 2021-09-30 (Crawled : 17:00) - prnewswire.com
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 1.19%
H: 0.37%
C: -0.09%
Healthtech Solutions, Inc. Announces Appointment of Paul Mann to the Board of Directors
Published: 2021-07-20 (Crawled : 21:00) - globenewswire.com
MS | News 0 d | $93.88 0.13% 2.7M
|
Finance
|
| O: 1.0%
H: 3.01%
C: 2.62%
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: -0.32%
H: 7.38%
C: 5.46%
PolarityTE Announces Completion of Target Enrollment in Diabetic Foot Ulcer Trial
Published: 2021-01-21 (Crawled : 15:00) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 0.93%
H: 4.63%
C: 0.0%
trial diabetic diabetes enroll
PolarityTE to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022
Published: 2022-09-13 (Crawled : 13:20) - biospace.com/
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 0.35%
H: 13.98%
C: 8.06%
global conference
PolarityTE Reports Fiscal Year 2021 Financial Results and Provides Business Update
Published: 2022-03-30 (Crawled : 12:00) - prnewswire.com
PTE | $0.241 -0.82% -6.68% 0
|
Consumer Durables
|
| O: 0.18%
H: 1.55%
C: -4.95%
results
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M
|
Consumer Services
CZOO | $11.04 121.24% 11M
|
LICN | $0.9107 62.63% 14M
|
BOF | $1.87 59.83% 100M
|
AMST | $3.18 59.0% 67M
|
Technology Services
SKIL 4 | $8.72 52.72% 410K
|
Information
MTC | $3.31 47.77% 7.7M
|
Technology Services
MULN | News | $3.915 43.41% 12M
|
Information
WIMI | $1.04 43.37% 17M
|
Technology Services
RILY | $29.755 36.99% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.